Where do new medicines start? They start in the lab, where scientists study the biological mechanisms that contribute to good health or, when they go awry, cause disease. Beaker highlights interesting science, Sanford-Burnham Medical Research Institute and our supporters.
Beaker's Latest Posts
TGF-beta signals stem cells to become heart muscle cells.
Sanford-Burnham scientists have identified the B- and T-lymphocyte attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study provides clarity on how T-cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
The 2013 World Stem Cell Summit is an opportunity to share knowledge and advance collaborations in stem cell and regenerative medicine. The Summit brings global stakeholders in research, discovery and development of lifesaving cures and therapies mixed with experts in regulation, legislation, finance, reimbursement and patient advocacy. What: 2013 World Stem Cell Summit When: DecemberRead More
Kristiina Vuori, M.D., Ph.D., Sanford-Burnham’s president and interim CEO, joins the leaders of an estimated 5,500 U.S. organizations in endorsing #GivingTuesday, the new holiday tradition that sets aside the Tuesday after Thanksgiving Day (December 3 this year) as a national day of giving to nonprofit causes and celebrating the power of philanthropy.
Healthy (left) and mutated (right) neurons exposed to pesticides. The green color indicates cell death, the red color indicates dopamine
Log in to leave a comment